IDEAYA Biosciences to Participate in Investor Conferences in March 2023
IDEAYA Biosciences (NASDAQ: IDYA) announced its participation in two key investor conferences in March 2023. The first is the Oppenheimer 33rd Annual Healthcare Conference on March 14, where CSO Michael White and CMO Darrin Beaupre will engage in a fireside chat. The second is the Guggenheim 4th Annual Healthy Altitudes Summit on March 15, featuring CEO Yujiro S. Hata. Live audio webcasts will be available on IDEAYA's website, with replays accessible for 30 days post-event. The company is committed to developing targeted therapeutics using molecular diagnostics, focusing on synthetic lethality in oncology.
- None.
- None.
Oppenheimer 33rd Annual Healthcare Conference
- Fireside chat with
Michael White , Chief Scientific Officer andDarrin Beaupre , Chief Medical Officer, hosted byMatthew Biegler , Executive Director and Senior Analyst
Guggenheim 4th Annual Healthy Altitudes Summit
- Fireside chat with
Yujiro S. Hata , Chief Executive Officer, hosted byCharles Zhu , Ph.D. Vice President and Equity Research Analyst
A live audio webcast of conference events, as permitted by conference host, will be available at the "Investors/News and Events/Investor Calendar" section of the IDEAYA website at https://ir.ideayabio.com/events. A replay of available webcasts will be accessible for 30 days following the live event.
About
IDEAYA is a synthetic lethality-focused precision medicine oncology company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. IDEAYA's approach integrates capabilities in identifying and validating translational biomarkers with drug discovery to select patient populations most likely to benefit from its targeted therapies. IDEAYA is applying its early research and drug discovery capabilities to synthetic lethality – which represents an emerging class of precision medicine targets.
Forward-Looking Statements
This press release contains forward-looking statements, including, but not limited to, statements related to participation in and/or presentation at certain investor relations events. IDEAYA undertakes no obligation to update or revise any forward-looking statements. For a further description of the risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to the business of IDEAYA in general, see IDEAYA's Quarterly Report on Form 10-Q filed on
Investor and Media Contact
Senior Vice President and Chief Financial Officer
investor@ideayabio.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/ideaya-biosciences-to-participate-in-investor-conferences-in-march-2023-301758685.html
SOURCE
FAQ
What investor conferences is IDEAYA participating in March 2023?
Who will participate in the Oppenheimer Healthcare Conference for IDEAYA?
When is the Guggenheim Healthy Altitudes Summit?
How can I listen to IDEAYA's conference presentations?